Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Other Operating Expenses (2016 - 2025)

Avanos Medical's Other Operating Expenses history spans 12 years, with the latest figure at $600000.0 for Q3 2024.

  • For Q3 2024, Other Operating Expenses rose 106.32% year-over-year to $600000.0; the TTM value through Dec 2024 reached -$1.7 million, up 87.22%, while the annual FY2023 figure was -$13.3 million, 343.33% down from the prior year.
  • Other Operating Expenses for Q3 2024 was $600000.0 at Avanos Medical, up from -$2.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $11.4 million in Q4 2021 and bottomed at -$41.9 million in Q4 2020.
  • The 5-year median for Other Operating Expenses is -$2.0 million (2022), against an average of -$4.9 million.
  • The largest annual shift saw Other Operating Expenses tumbled 4555.56% in 2020 before it soared 127.21% in 2021.
  • A 5-year view of Other Operating Expenses shows it stood at -$41.9 million in 2020, then skyrocketed by 127.21% to $11.4 million in 2021, then tumbled by 101.75% to -$200000.0 in 2022, then plummeted by 1150.0% to -$2.5 million in 2023, then surged by 124.0% to $600000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Other Operating Expenses are $600000.0 (Q3 2024), -$2.1 million (Q2 2024), and -$200000.0 (Q1 2024).